Study of Sacituzumab Govitecan in Patients With Solid Tumor
Clinical trial NCT05119907 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05119907
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2026-10-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.